Related Experiment Video
Updated: Jun 3, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Inflammatory biomarkers and symptom presence in pediatric corrosive substance ingestion: a retrospective study
Hülya İpek1, Gül Doğan2, Mehmet Metin2
1Department of Pediatric Surgery, Faculty of Medicine, Hitit University, Çorum, Turkey. drhulyad@yahoo.com.
Insights
In pediatric corrosive ingestion, inflammatory biomarkers like neutrophil-to-lymphocyte ratio (NLR) correlate with symptoms but have limited diagnostic value. Endoscopic evaluation remains crucial for assessing esophageal injury severity.
Area of Science:
- Pediatric Gastroenterology
- Clinical Toxicology
- Inflammatory Biomarkers
Background:
- Corrosive substance ingestion poses significant risks to children, with symptoms often not correlating with esophageal injury severity.
- Early assessment is challenging, prompting investigation into accessible inflammatory biomarkers as adjunctive diagnostic tools.
Purpose of the Study:
- To evaluate the association between specific inflammatory biomarkers and symptom presence in pediatric patients who ingested corrosive substances.
- To assess the discriminative performance of these biomarkers in identifying symptomatic cases.
Main Methods:
- Retrospective analysis of 213 pediatric patients (0-18 years) with corrosive ingestion.
- Calculation and analysis of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammation value (PIV).
- Comparison of biomarker levels between symptomatic and asymptomatic groups.
Main Results:
- Symptomatic patients (8.5%) exhibited higher neutrophil and lower lymphocyte levels, leading to significantly elevated NLR (P=.002).
- Elevated PLR, SII, SIRI, and PIV were also observed in symptomatic children.
- NLR demonstrated the best discriminative performance (AUC=0.723) for symptom presence.
Conclusions:
- Inflammatory biomarkers, especially NLR, show an association with symptom presence in pediatric corrosive ingestion.
- However, their current diagnostic or prognostic utility is limited, and they cannot replace endoscopic evaluation.
- Further prospective research is necessary to confirm the clinical applicability of these biomarkers.
Background:
Corrosive substance ingestion is a significant clinical problem in the pediatric population, with challenges in early assessment due to the inconsistent relationship between symptoms and the severity of esophageal injury. Easily accessible inflammatory biomarkers have been proposed as adjunctive tools for early clinical evaluation. This study aimed to evaluate the association between inflammatory biomarkers and symptom presence in pediatric patients with corrosive substance ingestion and to assess their discriminative performance.
Methods:
This retrospective study included 213 pediatric patients (aged 0-18 years) with corrosive substance ingestion. Patients were classified according to the type of ingested substance and the presence of symptoms. Inflammatory biomarkers including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), and pan-immune-inflammation value (PIV) were calculated, and their association with symptom presence was analyzed.
Results:
The proportion of symptomatic patients was 8.5% (n = 18), with vomiting and hypersalivation being the most common symptoms. Neutrophil levels were higher (P = 0.016) and lymphocyte levels were lower (P = 0.007) in symptomatic patients, resulting in significantly elevated NLR (P = 0.002). PLR (P = 0.006), SII (P = 0.004), SIRI (P = 0.020), and PIV (P = 0.019) were also higher. NLR showed the best discriminative performance (AUC = 0.723; 95% CI: 0.557-0.888), with 61.1% sensitivity and 90.3% specificity at a cut-off of 2.15. Logistic regression confirmed a significant association between elevated NLR and symptom presence.
Conclusions:
Inflammatory biomarkers, particularly NLR, were associated with symptom presence; however, their diagnostic or prognostic value is limited. They should not replace endoscopic evaluation. Further prospective studies are needed to validate their clinical utility.
Related Concept Videos
Toxidromes: Clinical Features
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Prevention of Further Absorption of Poison
Acute Coronary Syndrome III: Diagnostic Studies
